Lerna Biopharma
Founded in 2020, Lerna Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver diseases and ophthalmic disorders, with operations in Singapore, China and USA. Using proprietary platforms backed by novel biology and chemistry insights, Lerna aims to improve quality of life for millions of patients worldwide through creating highly specific, stable and potent nucleic acid-based medicines for the treatment of a broad range of diseases. In December 2021, Lerna successfully closed an over-subscribed US$19.2 million pre-Series A funding round led by BioTrack Capital, with participation from Hyfinity Investments, Legendstar Capital and other renowned investors.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
4
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Lerna Biopharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
Showing 1 of 4 verified contacts
Top roles at Lerna Biopharma
3 distinct titles indexed · top 3 shown.
- 1finance manager
- 1senior research associate
- 1vice president of biology
Sign up to unlock all 4 contacts at Lerna Biopharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Lerna Biopharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.